Kras or Hras is known to be spontaneously activated in precancerous mammary epithelial cells to instigate tumor formation in transgenic models of breast cancer, including in mice transgenic for Wnt1 under the control of mouse mammary tumor virus (MMTV) LTR (30, 31). Here, HRAS is linked to neoplasm.